VICE president, Sub Saharan Africa and South Africa of AstraZeneca, Mr. Anver Moola has assured that his company would deliver on its promise of getting life-changing medicines to patients, quickly, safely and efficiently. Moola who made the pledge at the corporate launch of AstraZeneca in Nigeria, at Ikeja, said the company would not only increase its presence in the country, by investing in people and products but would also offer doctor education initiatives by organizing symposia, patient education and access programmes.
The AstraZeneca boss said his company was one of the worldâ€™s leading pharmaceutical firms with presence in 100 countries and growing presence in emerging markets, stressing that it employed 65,000 employees and had 26 manufacturing sites in 18 countries. Noting that the pharmaceutical firm has 144 research projects in its project pipeline, including small molecule and biological products, Moola stressed that in 2008 alone, Astrazeneca invested more than $5billion in research and development to access external scientific innovation that broaden its platform for disease research.
Moola said the firm aims to ensure consistent high standards of corporate social responsibility worldwide, adding that it seeks not only to make positive difference within its local communities but also exhibits core commitment to good safety, health and environmental performances.
Director general of the National Agency for Food and Drug Administration and Control (NAFDAC), Dr. Paul Orhi, in his address lauded AstraZeneca for its development of quality pharmaceutical products and maintenance of a satisfactory good manufacturing practice.